Prognostic analysis of related factors of adverse reactions to immunotherapy in advanced gastric cancer and establishment of a nomogram model

doi:10.4251/wjgo.v16.i4.1268

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1929)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-5) series.

Item

Count

PDF

HTML

1107

Figures (1-5)

218

Tables (1-5)

193

Sum=1583

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

230

Sum=273

Apr 15, 2024 (publication date) through Feb 14, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1268-1280
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1268

Table 4 Comparison of therapeutic effects between the two groups

Therapeutic effect	irAEs group (n = 63), n (%)	Non-irAEs group (n = 69), n (%)	χ²/t value	P value
PR	19 (30.1)	10 (14.5)	4.679	0.031
SD	35 (55.6)	39 (56.5)	0.012	0.913
PD	9 (14.3)	20 (29.0)	4.12	0.042

irAEs: Immune-related adverse reactions; PR: Partial remission; SD: Stable disease; PD: Disease progression.

Citation: He XX, Du B, Wu T, Shen H. Prognostic analysis of related factors of adverse reactions to immunotherapy in advanced gastric cancer and establishment of a nomogram model. World J Gastrointest Oncol 2024; 16(4): 1268-1280
URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1268.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1268